Not applicableStudy completedNCT01341665What this trial is testingSubclassification of the Syndrome of Inappropriate ADH SecretionWho this might be right forHyponatremia University of Wuerzburg 50
Testing effectiveness (Phase 2)Study completedNCT02009878What this trial is testingA PK Study of 3 Dosages of Tolvaptan in Patients With Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)Who this might be right forSyndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Otsuka Pharmaceutical Development & Commercialization, Inc. 30
Not applicableStudy completedNCT04119206What this trial is testingTolvaptan Versus Fluid Restriction in SIADHWho this might be right forHyponatremiaSyndrome of Inappropriate ADH (SIADH) SecretionPituitary University of Erlangen-Nürnberg Medical School 334
Large-scale testing (Phase 3)Ended earlyNCT00728091What this trial is testingA Phase III Study Evaluating the Efficacy and Safety of Satavaptan Versus Placebo in Patients With Dilutional HyponatremiaWho this might be right forHyponatremiaInappropriate ADH Syndrome Sanofi 2
Large-scale testing (Phase 3)Study completedNCT00264927What this trial is testingEfficacy and Safety of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone SecretionWho this might be right forInappropriate ADH SyndromeHyponatremia Sanofi 77
Testing effectiveness (Phase 2)Study completedNCT00032734What this trial is testingEfficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone SecretionWho this might be right forSyndrome of Inappropriate ADH (SIADH) SecretionHyponatremia Sanofi 35
Large-scale testing (Phase 3)Study completedNCT03048747What this trial is testingTrial to Investigate the Efficacy and Safety of Tolvaptan in Patients With Hyponatremia in SIADHWho this might be right forSyndrome of Inappropriate Antidiuretic Hormone Secretion Otsuka Pharmaceutical Co., Ltd. 16
Not applicableStudy completedNCT02573077What this trial is testingAn Observational Study Measuring Outcomes in Cancer Patients Treated for Moderate to Severe Hyponatremia in ItalyWho this might be right forHyponatremiaSyndrome of Inappropriate ADH (SIADH) SecretionCancer Otsuka Pharmaceutical Europe Ltd 69
Large-scale testing (Phase 3)Study completedNCT00264914What this trial is testingSafety and Efficacy of SR121463B in Patients With Syndrome of Inappropriate Antidiuretic Hormone SecretionWho this might be right forInappropriate ADH SyndromeHyponatremia Sanofi 57
Not applicableLooking for participantsNCT04790175What this trial is testingSamsca Post-marketing General Drug Use-results Survey in Patients with Hyponatremia in SIADHWho this might be right forAntidiuretic Hormone, Inappropriate Secretion Otsuka Pharmaceutical Co., Ltd. 300
Not applicableStudy completedNCT02548845What this trial is testingAn Observational Study to Describe the Adherence to the SEOM Algorithm for the Treatment of Hyponatraemia in SpainWho this might be right forHyponatremiaSyndrome of Inappropriate ADH (SIADH) Secretion Otsuka Pharmaceutical Europe Ltd 70
Not applicableStudy completedNCT02545101What this trial is testingAn Observational Study on Real-world Use and Outcomes of Patients Treated With Tolvaptan for Hyponatraemia Due to SIADHWho this might be right forHyponatremiaSyndrome of Inappropriate ADH (SIADH) Secretion Otsuka Pharmaceutical Europe Ltd 100
Post-approval studies (Phase 4)WithdrawnNCT00298753What this trial is testingUrinary Aquaporine 2 in Patients With Syndrome of Inappropriate ADH-secretion Caused by Treatment With Antiepileptic MedicineWho this might be right forSyndrome of Inappropriate ADH-secretion Regional Hospital Holstebro
Not applicableLooking for participantsNCT06821802What this trial is testingProtein Supplementation in Hyponatremia Due to the Syndrome of Inappropriate AntidiuresisWho this might be right forHyponatremiaSyndrome of Inappropriate Antidiuresis University Hospital, Basel, Switzerland 70